Selskabets formål er at drive virksomhed ved at tilbyde IVF fertilitetsbehandling i en high-end fertilitetsklinik med rådighed over den nyeste teknologi på fertilitetsområdet.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 6.6 mio. | -918 t. | 4.7 mio. | -2.4 mio. | 6 | |
CVR: 42485578
Compared to 627 companies in Speciallægers aktiviteter
Comparison is based on industry median values
V & CO STATSAUTORISERET REVISIONSANPARTSSELSKAB resigned as auditor
Companies in the same industry and area
CVR 43908138
CVR 45739120
CVR 38159283
CVR 26689929
CVR 30855116
junoIVF ApS is currently facing significant financial challenges, highlighted by a negative profit of 917,597 DKK in 2025 and a concerning equity position of -2,416,821 DKK. Revenue has shown some growth, reaching 6,573,848 DKK in 2025, but the overall trend in profitability remains unstable, with losses recorded in previous years, including a profit of 115,428 DKK in 2023 followed by a substantial loss in 2024. The company's equity has been consistently negative, raising concerns about its financial sustainability and ability to attract investment. Positioned within the specialized medical services industry, junoIVF ApS must address its profitability and equity issues to improve its standing and operational viability.
AI-generated summary